Medical Heart Failure Treatment Devices sector
Strategic acquirers, private equity (buyout funds and growth funds) firms, and valuation benchmarks for Medical Heart Failure Treatment Devices
1.1 - About Medical Heart Failure Treatment Devices sector
Companies in the Medical Heart Failure Treatment Devices category design implantable and external technologies to treat and manage congestive heart failure. Their offerings improve cardiac output, monitor hemodynamics, and support guideline-directed therapy using continuous data capture and remote care. These vendors help clinicians reduce decompensation risk, personalize interventions, and streamline follow-up, making them relevant strategic buyers in cardiovascular devices for expanding heart failure care portfolios and outcomes-driven service lines.
These companies build left ventricular assist device platforms with implantable pumps and controller hardware to augment circulation in advanced heart failure. They offer cardiac resynchronization therapy pacemakers and defibrillators to restore ventricular synchrony and reduce symptoms. Many provide implantable pulmonary artery pressure sensors that stream data to clinician dashboards, alongside baroreflex activation therapy systems for autonomic modulation. They complement devices with remote patient monitoring portals, wearable cardiac patches, and care management software integrated with EHRs to guide titration and early intervention.
Primary customers include hospital cardiovascular service lines and heart failure centers, electrophysiology departments, and outpatient cardiology practices. Outcomes typically include reduced hospitalizations and readmissions through proactive monitoring, improved functional status via optimized therapy and resynchronization, faster clinical decision-making with longitudinal device-derived data, and lower total cost of care from fewer acute events and streamlined follow-up pathways. Health systems also benefit from scalable remote care programs supported by connected telemetry and analytics.
2. Buyers in the Medical Heart Failure Treatment Devices sector
2.1 Top strategic acquirers of Medical Heart Failure Treatment Devices companies
Element Science
- Description: Provider of wearable medical devices and digital health solutions that apply user-centric design, data science and machine learning to continuously monitor and treat patients at risk of sudden cardiac arrest, including a patch-based wearable cardioverter defibrillator that prevents sudden cardiac death.
- Key Products:
- Jewel Wearable Defibrillator: Patch-style device that continuously monitors heart rhythms and automatically delivers life-saving shocks, using data science to prevent sudden cardiac arrest while remaining comfortable and user-friendly
- Jewel® Patch Wearable Cardioverter Defibrillator (Patch-WCD): FDA-approved discreet patch defibrillator for patients at temporary high risk of SCA, offering constant monitoring and rapid therapy without implants
- Wearable Medical Device with Disposable & Reusable Components: Device architecture separating single-use and reusable parts to reduce cost and simplify maintenance while delivering cardiac monitoring and defibrillation functions.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
2.2 - Strategic buyer groups for Medical Heart Failure Treatment Devices sector
M&A buyer group 1: Arrhythmia Treatment Devices
AtriCure
- Type: N/A
- Employees: ●●●●●
- Description: Provider of medical device technologies for treating atrial fibrillation and related complications, delivering FDA-approved ablation, left atrial appendage exclusion, hybrid therapy and cryoablation solutions used by electrophysiologists and cardiothoracic surgeons worldwide to improve outcomes and manage post-operative pain.
- Key Products:
- Isolator Synergy Clamps: Bipolar RF surgical clamps that ablate cardiac tissue, creating isolation lesions to treat persistent atrial fibrillation during concomitant coronary bypass or valve repair procedures
- AtriClip LAA Exclusion System: Implantable clip applied under direct visualization to occlude the left atrial appendage during cardiac surgery, eliminating blood flow and lowering stroke risk
- EPi-Sense Coagulation Device: Epicardial RF device used in hybrid convergent procedures to deliver linear lesions for long-standing persistent atrial fibrillation when combined with specified endocardial catheters
- cryoSPHERE Cryoablation Probes: Single-use probes that freeze peripheral or intercostal nerves producing temporary nerve blocks, providing non-opioid post-surgical pain relief for adult and adolescent patients.
Buyer group 2: ████████ ████████
●● companiesBuyer group 3: ████████ ████████
●● companies3. Investors and private equity firms in Medical Heart Failure Treatment Devices sector
3.1 - Buyout funds in the Medical Heart Failure Treatment Devices sector
2.2 - Strategic buyer groups for Medical Heart Failure Treatment Devices sector
4 - Top valuation comps for Medical Heart Failure Treatment Devices companies
4.2 - Public trading comparable groups for Medical Heart Failure Treatment Devices sector
Valuation benchmark group 1: Cardiovascular and Electrophysiology Device Manufacturers
Boston Scientific
- Enterprise value: $●●●m
- Market Cap: $●●●m
- EV/Revenue: ●.●x
- EV/EBITDA: ●●.●x
- Description: Provider of innovative medical solutions, developing and manufacturing medical devices for interventional medical specialties including cardiology, oncology, endoscopy, and neuromodulation, aimed at improving patient health and transforming lives worldwide.
- Key Products:
- Cardiac Devices: Devices for diagnosing and treating heart conditions including stents, pacemakers, and defibrillators
- Oncology Solutions: Minimally invasive medical devices for diagnosing and treating various cancers
- Endoscopy Devices: Tools for diagnosing and treating gastrointestinal and pulmonary conditions
- Neuromodulation Devices: Electronic implantable technologies for managing chronic pain and neurological disorders
- Peripheral Intervention Devices: Technologies for treating peripheral artery and vein conditions.